Cargando…

Id2 deletion attenuates Apc-deficient ileal tumor formation

The expression level of inhibitor of DNA binding 2 (Id2) is increased in colorectal carcinomas and is positively correlated with poor prognosis. However, the functional significance of Id2 in intestinal tumorigenesis has not been fully defined using genetic approaches. Here, we show that Id2 promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Biyajima, Kyoko, Kakizaki, Fumihiko, Shen, Xiaodong, Mori, Kentaro, Sugai, Manabu, Taketo, M. Mark, Yokota, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542283/
https://www.ncbi.nlm.nih.gov/pubmed/26163528
http://dx.doi.org/10.1242/bio.012252
_version_ 1782386510204502016
author Biyajima, Kyoko
Kakizaki, Fumihiko
Shen, Xiaodong
Mori, Kentaro
Sugai, Manabu
Taketo, M. Mark
Yokota, Yoshifumi
author_facet Biyajima, Kyoko
Kakizaki, Fumihiko
Shen, Xiaodong
Mori, Kentaro
Sugai, Manabu
Taketo, M. Mark
Yokota, Yoshifumi
author_sort Biyajima, Kyoko
collection PubMed
description The expression level of inhibitor of DNA binding 2 (Id2) is increased in colorectal carcinomas and is positively correlated with poor prognosis. However, the functional significance of Id2 in intestinal tumorigenesis has not been fully defined using genetic approaches. Here, we show that Id2 promotes ileal tumor initiation in Apc-deficient mice. Expression of Id2 was stimulated by Wnt signaling through the enhancer region of the Id2 promoter at the early stage of tumorigenesis in Apc(+/Δ716) (Apc(Δ716)) mice. Genetic depletion of Id2 in Apc(Δ716) mice caused ∼80% reduction in the number of ileal polyps, but had little effect on tumor size. Notably, the lack of Id2 increased the number of apoptotic cells in the normal crypt epithelium of the mice. Furthermore, DNA microarray analysis revealed that the expression level of Max dimerization protein 1 (Mxd1), known as a c-Myc antagonist, was specifically increased by Id2 deletion in the ileal intestinal epithelium of Apc(Δ716) mice. In contrast, the protein level of c-Myc, but not the mRNA level, was decreased by loss of Id2 in these mice. These results indicate that loss of Id2 inhibits tumor initiation by up-regulation of Mxd1 and down-regulation of c-Myc in Apc(Δ716) mice.
format Online
Article
Text
id pubmed-4542283
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Company of Biologists
record_format MEDLINE/PubMed
spelling pubmed-45422832015-09-16 Id2 deletion attenuates Apc-deficient ileal tumor formation Biyajima, Kyoko Kakizaki, Fumihiko Shen, Xiaodong Mori, Kentaro Sugai, Manabu Taketo, M. Mark Yokota, Yoshifumi Biol Open Research Article The expression level of inhibitor of DNA binding 2 (Id2) is increased in colorectal carcinomas and is positively correlated with poor prognosis. However, the functional significance of Id2 in intestinal tumorigenesis has not been fully defined using genetic approaches. Here, we show that Id2 promotes ileal tumor initiation in Apc-deficient mice. Expression of Id2 was stimulated by Wnt signaling through the enhancer region of the Id2 promoter at the early stage of tumorigenesis in Apc(+/Δ716) (Apc(Δ716)) mice. Genetic depletion of Id2 in Apc(Δ716) mice caused ∼80% reduction in the number of ileal polyps, but had little effect on tumor size. Notably, the lack of Id2 increased the number of apoptotic cells in the normal crypt epithelium of the mice. Furthermore, DNA microarray analysis revealed that the expression level of Max dimerization protein 1 (Mxd1), known as a c-Myc antagonist, was specifically increased by Id2 deletion in the ileal intestinal epithelium of Apc(Δ716) mice. In contrast, the protein level of c-Myc, but not the mRNA level, was decreased by loss of Id2 in these mice. These results indicate that loss of Id2 inhibits tumor initiation by up-regulation of Mxd1 and down-regulation of c-Myc in Apc(Δ716) mice. The Company of Biologists 2015-07-10 /pmc/articles/PMC4542283/ /pubmed/26163528 http://dx.doi.org/10.1242/bio.012252 Text en © 2015. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Biyajima, Kyoko
Kakizaki, Fumihiko
Shen, Xiaodong
Mori, Kentaro
Sugai, Manabu
Taketo, M. Mark
Yokota, Yoshifumi
Id2 deletion attenuates Apc-deficient ileal tumor formation
title Id2 deletion attenuates Apc-deficient ileal tumor formation
title_full Id2 deletion attenuates Apc-deficient ileal tumor formation
title_fullStr Id2 deletion attenuates Apc-deficient ileal tumor formation
title_full_unstemmed Id2 deletion attenuates Apc-deficient ileal tumor formation
title_short Id2 deletion attenuates Apc-deficient ileal tumor formation
title_sort id2 deletion attenuates apc-deficient ileal tumor formation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542283/
https://www.ncbi.nlm.nih.gov/pubmed/26163528
http://dx.doi.org/10.1242/bio.012252
work_keys_str_mv AT biyajimakyoko id2deletionattenuatesapcdeficientilealtumorformation
AT kakizakifumihiko id2deletionattenuatesapcdeficientilealtumorformation
AT shenxiaodong id2deletionattenuatesapcdeficientilealtumorformation
AT morikentaro id2deletionattenuatesapcdeficientilealtumorformation
AT sugaimanabu id2deletionattenuatesapcdeficientilealtumorformation
AT taketommark id2deletionattenuatesapcdeficientilealtumorformation
AT yokotayoshifumi id2deletionattenuatesapcdeficientilealtumorformation